Mark Christianson, VP of Market Development at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 334,000 shares at $0.60 ($200K) on 2020-06-12, disclosed to the SEC on 2020-06-16.
Open-market sale of $200k NMTC by VP of Market Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NMTC | SELL | 2026-03-16 | $734 | — | Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |